These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 6541864

  • 1. Decreased serum lithium during verapamil therapy.
    Weinrauch LA, Belok S, D'Elia JA.
    Am Heart J; 1984 Nov; 108(5):1378-80. PubMed ID: 6541864
    [No Abstract] [Full Text] [Related]

  • 2. Verapamil: a cause of sudden death in a patient with hypertrophic cardiomyopathy.
    Perrot B, Danchin N, Terrier de la Chaise A.
    Br Heart J; 1984 Mar; 51(3):352-4. PubMed ID: 6538092
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Choreoathetosis induced by verapamil and lithium treatment.
    Helmuth D, Ljaljevic Z, Ramirez L, Meltzer HY.
    J Clin Psychopharmacol; 1989 Dec; 9(6):454-5. PubMed ID: 2512332
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Verapamil in bipolar illness.
    Solomon L, Williamson P.
    Can J Psychiatry; 1986 Jun; 31(5):442-4. PubMed ID: 3731014
    [Abstract] [Full Text] [Related]

  • 9. Neurotoxicity caused by lithium-verapamil synergism.
    Price WA, Giannini AJ.
    J Clin Pharmacol; 1986 Jun; 26(8):717-9. PubMed ID: 3793965
    [No Abstract] [Full Text] [Related]

  • 10. Atrial systole and left ventricular filling in hypertrophic cardiomyopathy: effect of verapamil.
    Bonow RO, Frederick TM, Bacharach SL, Green MV, Goose PW, Maron BJ, Rosing DR.
    Am J Cardiol; 1983 May 01; 51(8):1386-91. PubMed ID: 6682616
    [Abstract] [Full Text] [Related]

  • 11. Adverse effects of atrial fibrillation and syncope induced by calcium-channel blockers in hypertrophic cardiomyopathy.
    Doiuchi J, Hamada M, Ochi T, Ito T, Kokubu T.
    Clin Cardiol; 1985 Mar 01; 8(3):176-9. PubMed ID: 4038927
    [Abstract] [Full Text] [Related]

  • 12. [Echocardiographic and electrocardiographic evaluation of the effects of propranolol and verapamil in obstructive hypertrophic cardiomyopathy].
    Crittin J, Mayor C, Bloch A.
    Ann Cardiol Angeiol (Paris); 1984 Apr 01; 33(3):185-9. PubMed ID: 6375537
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic evaluation of pindolol and verapamil in hypertrophic obstructive cardiomyopathy.
    Masini V, Ceci V, Malinconico U, Milazzotto F.
    G Ital Cardiol; 1981 Apr 01; 11(11):1729-37. PubMed ID: 7044864
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Left ventricular end-diastolic pressure-volume relationships in hypertrophic cardiomyopathy. Changes induced by verapamil.
    Tendera M, Polonski L, Kozielska E.
    Chest; 1983 Jul 01; 84(1):54-7. PubMed ID: 6683147
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Verapamil therapy: a new approach to pharmacologic treatment of hypertrophic cardiomyopathy.
    Rosing DR, Kent KM, Maron BJ, Condit J, Epstein SE.
    Chest; 1980 Jul 01; 78(1 Suppl):239-47. PubMed ID: 6995039
    [Abstract] [Full Text] [Related]

  • 19. [Personal experience with the long-term administration of verapamil in hypertrophic cardiomyopathies].
    Gregor P, Widimský P, Cervenka V, Vísek V, Dvorák J, Sládková T.
    Vnitr Lek; 1986 Dec 01; 32(12):1179-87. PubMed ID: 3824917
    [No Abstract] [Full Text] [Related]

  • 20. Verapamil and norverapamil plasma concentrations during long-term therapy in patients with hypertrophic obstructive cardiomyopathy.
    Woodcock BG, Hopf R, Kaltenbach M.
    J Cardiovasc Pharmacol; 1980 Dec 01; 2(1):17-23. PubMed ID: 6154201
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.